147 related articles for article (PubMed ID: 15026335)
1. A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Wiley KE; Turner A; Li G; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2004 Mar; 64(6):1997-9. PubMed ID: 15026335
[TBL] [Abstract][Full Text] [Related]
2. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.
Kibel AS; Suarez BK; Belani J; Oh J; Webster R; Brophy-Ebbers M; Guo C; Catalona WJ; Picus J; Goodfellow PJ
Cancer Res; 2003 May; 63(9):2033-6. PubMed ID: 12727815
[TBL] [Abstract][Full Text] [Related]
3. Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage.
Xu J; Langefeld CD; Zheng SL; Gillanders EM; Chang BL; Isaacs SD; Williams AH; Wiley KE; Dimitrov L; Meyers DA; Walsh PC; Trent JM; Isaacs WB
Hum Genet; 2004 Aug; 115(3):255-62. PubMed ID: 15185141
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Turner AR; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Prostate; 2003 Jun; 56(1):37-44. PubMed ID: 12746845
[TBL] [Abstract][Full Text] [Related]
5. Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.
Xie CC; Lu L; Sun J; Zheng SL; Isaacs WB; Gronberg H; Xu J
J Hum Genet; 2011 Jul; 56(7):496-502. PubMed ID: 21633361
[TBL] [Abstract][Full Text] [Related]
6. CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan.
Huang SP; Yu CC; Liu CC; Wu TT; Huang CH; Wu MT
Urol Int; 2008; 81(1):36-40. PubMed ID: 18645269
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study.
Zheng SL; Mychaleckyj JC; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Chang BL; von Kap-Herr C; Carpten JD; Pettenati M; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Mutat Res; 2003 Jul; 528(1-2):45-53. PubMed ID: 12873722
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
[TBL] [Abstract][Full Text] [Related]
9. Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer.
Chang B; Zheng SL; Isaacs SD; Wiley KE; Carpten JD; Hawkins GA; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Int J Cancer; 2001 Nov; 95(6):354-9. PubMed ID: 11668516
[TBL] [Abstract][Full Text] [Related]
10. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
[TBL] [Abstract][Full Text] [Related]
11. Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.
Landa I; Montero-Conde C; Malanga D; De Gisi S; Pita G; Leandro-García LJ; Inglada-Pérez L; Letón R; De Marco C; Rodríguez-Antona C; Viglietto G; Robledo M
Endocr Relat Cancer; 2010 Jun; 17(2):317-28. PubMed ID: 20075119
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
13. Role of HPC2/ELAC2 in hereditary prostate cancer.
Wang L; McDonnell SK; Elkins DA; Slager SL; Christensen E; Marks AF; Cunningham JM; Peterson BJ; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
Cancer Res; 2001 Sep; 61(17):6494-9. PubMed ID: 11522646
[TBL] [Abstract][Full Text] [Related]
14. CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.
Pasquali D; Circelli L; Faggiano A; Pancione M; Renzullo A; Elisei R; Romei C; Accardo G; Coppola VR; De Palma M; Ferolla P; Grimaldi F; Colao A; Colantuoni V
Eur J Endocrinol; 2011 Mar; 164(3):397-404. PubMed ID: 21177330
[TBL] [Abstract][Full Text] [Related]
15. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
16. CDKN1B Val 109 Gly variant is not related to risk of prostate cancer.
Zhu L; Wang J; Yue C; Yuan W; Zhang W; Shi L; Mi Y; Wu X; Zhang LF; Zuo L
J Cell Biochem; 2019 Oct; 120(10):18346-18356. PubMed ID: 31257659
[TBL] [Abstract][Full Text] [Related]
17. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.
Capasso M; McDaniel LD; Cimmino F; Cirino A; Formicola D; Russell MR; Raman P; Cole KA; Diskin SJ
J Cell Mol Med; 2017 Dec; 21(12):3224-3230. PubMed ID: 28667701
[TBL] [Abstract][Full Text] [Related]
18. Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer.
Cooney KA; Tsou HC; Petty EM; Miesfeldt S; Ping XL; Gruener AC; Peacocke M
Clin Cancer Res; 1999 Jun; 5(6):1387-91. PubMed ID: 10389923
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
Circelli L; Ramundo V; Marotta V; Sciammarella C; Marciello F; Del Prete M; Sabatino L; Pasquali D; Izzo F; Scala S; Colao A; Faggiano A; Colantuoni V;
J Cell Mol Med; 2015 Jul; 19(7):1735-41. PubMed ID: 25824098
[TBL] [Abstract][Full Text] [Related]
20. Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility.
Fitzgerald LM; Kumar A; Boyle EA; Zhang Y; McIntosh LM; Kolb S; Stott-Miller M; Smith T; Karyadi DM; Ostrander EA; Hsu L; Shendure J; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1520-8. PubMed ID: 23833122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
